📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sensulin

1.1 - Company Overview

Sensulin Logo

Sensulin

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of diabetes drug discovery focused on a once-a-day glucose-responsive insulin for type 1 and type 2 diabetes, designed to reduce hypoglycemia risk and long-term complications.

Products and services

  • Glucose-responsive insulin: A once-a-day therapy for type 1 and type 2 diabetes that adjusts to glucose levels to reduce hypoglycemia risk and long-term complications
  • Type 1 diabetes once-a-day insulin therapy: A product engineered to reduce hypoglycemia risk and long-term complications for type 1 patients with once-daily dosing
  • Type 2 diabetes once-a-day insulin therapy: A product developed to reduce hypoglycemia risk and long-term complications for type 2 patients with once-daily dosing

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sensulin

Calibrium Logo

Calibrium

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development, focused on developing a portfolio of novel drug candidates for the treatment of diabetes and related metabolic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Calibrium company profile →
Dexcom Logo

Dexcom

HQ: United States Website
  • Description: Provider of continuous glucose monitoring systems and data services for diabetes management, developing, manufacturing and distributing Dexcom G7 (real-time readings and alerts, compatible with Apple Watch), Dexcom G6 (for users 2+), and the OTC Stelo Glucose Biosensor System for adults not on insulin, plus Dexcom Clarity for glucose data analysis and Dexcom Follow/Share for remote data sharing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Dexcom company profile →
Biodel Logo

Biodel

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics for the treatment of diabetes, focused on developing and commercializing diabetes treatments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Biodel company profile →
Intarcia Logo

Intarcia

HQ: United States Website
  • Description: Provider of long-term therapies for chronic diseases, offering the MEDICITM Drug Delivery System for twice-yearly subcutaneous osmotic implants, ITCA 650 (twice-yearly exenatide implant) for type 2 diabetes, and an Ionic Liquid Platform converting injectable biologics and peptides into oral therapies; pipeline includes i2o-105s (long-acting GLP-1 receptor agonist), i2o-107 (long-acting amylin), and i2o-110 (dual agonist) for type 2 diabetes, obesity, and NASH.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intarcia company profile →
Protomer Logo

Protomer

HQ: United States Website
  • Description: Provider of pre-clinical biotechnology R&D focused on metabolic diseases, developing glucose-responsive insulin receptor agonist therapeutics and the Molecular Evolution of Peptide Sensors (MEPS) platform for creating therapeutic peptides and proteins with tunable, small-molecule-controlled activity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Protomer company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sensulin

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sensulin

2.2 - Growth funds investing in similar companies to Sensulin

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sensulin

4.2 - Public trading comparable groups for Sensulin

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sensulin

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sensulin

What does Sensulin do?

Sensulin is a provider of diabetes drug discovery focused on a once-a-day glucose-responsive insulin for type 1 and type 2 diabetes, designed to reduce hypoglycemia risk and long-term complications.

Who are Sensulin's competitors?

Sensulin's competitors and similar companies include Calibrium, Dexcom, Biodel, Intarcia, and Protomer.

Where is Sensulin headquartered?

Sensulin is headquartered in United States.

How many employees does Sensulin have?

Sensulin has 1,000 employees 🔒.

When was Sensulin founded?

Sensulin was founded in 2010 🔒.

What sector and industry vertical is Sensulin in?

Sensulin is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sensulin

Who are the top strategic acquirers in Sensulin's sector and industry

Top strategic M&A buyers and acquirers in Sensulin's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sensulin?

Top strategic M&A buyers groups and sectors for Sensulin include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sensulin's sector and industry vertical

Which are the top PE firms investing in Sensulin's sector and industry vertical?

Top PE firms investing in Sensulin's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sensulin's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sensulin's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sensulin's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sensulin include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sensulin's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sensulin?

The key public trading comparables and valuation benchmarks for Sensulin include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sensulin for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sensulin with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sensulin's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sensulin with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sensulin's' sector and industry vertical?

Access recent funding rounds and capital raises in Sensulin's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sensulin